Abstract
The Alzheimer's disease (AD) is a chronic neurodegenerative disease. Early diagnosis is extremely necessary and desirable, as it allows access to therapies that alleviate the symptoms from the disease onset. The ²-amyloid and ApoE4 neurochemical biomarkers are indicators that may be detected in physiological fluids such as cerebrospinal fluid, serum and plasma, to estimate the risk or pre…